Literature DB >> 20981762

Treatment of epilepsy in children with developmental disabilities.

Dewi Frances T Depositario-Cabacar1, Tesfaye-Getaneh Zelleke.   

Abstract

Children with developmental disabilities are at increased risk for epilepsy with a prevalence rate higher than the general population. Some of the more common developmental disorders in childhood and the features of epilepsy in these conditions are discussed. Specifically, autism, cerebral palsy, mental retardation, and attention deficit and hyperactivity disorder are reviewed. Ideal treatment for developmentally-disabled children with epilepsy entails maximal seizure control without any significant adverse effects from the anti-epileptic drugs and good quality of life. Antiepileptic drugs' cognitive and behavioral adverse effects tend to occur more frequently in these children. Careful selection of the appropriate medication and close monitoring for drug adverse effects is important. The specific adverse effects of the older and newer antiepileptic drugs are also reviewed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20981762     DOI: 10.1002/ddrr.116

Source DB:  PubMed          Journal:  Dev Disabil Res Rev        ISSN: 1940-5529


  14 in total

1.  Repetitive Transcranial Magnetic Stimulation/Behavioral Intervention Clinical Trial: Long-Term Follow-Up of Outcomes in Congenital Hemiparesis.

Authors:  Tonya L Rich; Jeremiah Menk; Linda E Krach; Timothy Feyma; Bernadette T Gillick
Journal:  J Child Adolesc Psychopharmacol       Date:  2016-02-23       Impact factor: 2.576

Review 2.  Childhood epilepsy and autism spectrum disorders: psychiatric problems, phenotypic expression, and anticonvulsants.

Authors:  Sally J Robinson
Journal:  Neuropsychol Rev       Date:  2012-08-09       Impact factor: 7.444

Review 3.  Pediatric indications for deep brain stimulation.

Authors:  Matthew F DiFrancesco; Casey H Halpern; Howard H Hurtig; Gordon H Baltuch; Gregory G Heuer
Journal:  Childs Nerv Syst       Date:  2012-07-25       Impact factor: 1.475

Review 4.  The medical care of children with autism.

Authors:  Hilde Olivié
Journal:  Eur J Pediatr       Date:  2012-01-18       Impact factor: 3.183

Review 5.  Therapeutic strategies in fragile X syndrome: dysregulated mGluR signaling and beyond.

Authors:  Christina Gross; Elizabeth M Berry-Kravis; Gary J Bassell
Journal:  Neuropsychopharmacology       Date:  2011-07-27       Impact factor: 7.853

Review 6.  The neurology of autism spectrum disorders.

Authors:  Shafali S Jeste
Journal:  Curr Opin Neurol       Date:  2011-04       Impact factor: 5.710

7.  Relaxation response-based yoga improves functioning in young children with autism: a pilot study.

Authors:  Lucy E Rosenblatt; Sasikanth Gorantla; Jodi A Torres; Rubin S Yarmush; Surita Rao; Elyse R Park; John W Denninger; Herbert Benson; Gregory L Fricchione; Bruce Bernstein; John B Levine
Journal:  J Altern Complement Med       Date:  2011-10-12       Impact factor: 2.579

8.  Excess mortality and causes of death in autism spectrum disorders: a follow up of the 1980s Utah/UCLA autism epidemiologic study.

Authors:  Deborah Bilder; Elizabeth L Botts; Ken R Smith; Richard Pimentel; Megan Farley; Joseph Viskochil; William M McMahon; Heidi Block; Edward Ritvo; Riva-Ariella Ritvo; Hilary Coon
Journal:  J Autism Dev Disord       Date:  2013-05

9.  Vagus nerve stimulation in the treatment of epilepsy: Payment policy perspectives.

Authors:  Saty Satya-Murti; Katie M Shepard; Sandra L Helmers
Journal:  Neurol Clin Pract       Date:  2013-10

10.  Psychopathology in pediatric epilepsy: role of antiepileptic drugs.

Authors:  Rochelle Caplan
Journal:  Front Neurol       Date:  2012-12-07       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.